All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Bookmark this article
To help navigate the exciting content being presented at the European Hematology Association (EHA) 2023 Congress, the AML Hub Steering Committee have provided their recommendations of the top abstracts to look for.
Abstract |
Type |
Title |
Presenter |
S248 |
Oral presentation |
SIERRA trial results with a targeted radiotherapy, Iomab-B, a myeloablative conditioning with reduced intensity tolerability yields high CR, long term survival in HSCT ineligible active R/R AML |
Boglarka Gyurkocza |
S310 |
Oral presentation |
Keith Pratz |
Abstract |
Type |
Title |
Presenter |
LB2711 |
Late breaking oral presentation |
BMT-CTN 1506 (MORPHO): a randomized trial of the FLT3 inhibitor gilteritinib as post-transplant maintenance for FLT3-ITD AML |
— |
LB2713 |
Late breaking oral presentation |
Activity, tolerability, and resistance profile of the menin inhibitor ziftomenib in adults with relapsed/refractory NPM1- mutated AML |
— |
S137 |
Oral presentation |
Impact of allogeneic hematopoietic cell transplantation in first complete remission plus FLT3 inhibition with quizartinib in acute myeloid leukemia with FLT3-ITD: results from QuANTUM-First |
Richard Schlenk |
S138 |
Oral presentation |
Validation of the revised 2022 European LeukemiaNet (ELN) risk stratification in adult patients with acute myeloid leukemia |
Marius Bill |
Subscribe to get the best content related to AML delivered to your inbox